关注
qingfeng zhu
qingfeng zhu
Tongji University;Sichuan University;Fudan University;Johns Hopkins University
在 jhmi.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival
L Danilova, WJ Ho, Q Zhu, T Vithayathil, A De Jesus-Acosta, NS Azad, ...
Cancer immunology research 7 (6), 886-895, 2019
2032019
Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma
PTM Gani F, Nagarajan N, Kim Y, Zhu Q, Luan L, Bhaijjee F, Anders RA
Ann Surg Oncol 23 (8), 2610-7, 2013
154*2013
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
S Berry, NA Giraldo, BF Green, TR Cottrell, JE Stein, EL Engle, H Xu, ...
Science 372 (6547), eaba2609, 2021
1472021
Neoadjuvant cabozantinib and nivolumab converts locally advanced HCC into resectable disease with enhanced antitumor immunity.
WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ...
Nature cancer 2 (9), 891-903, 2021
1352021
Characterization of the immune microenvironment in hepatocellular carcinoma
M Yarchoan, D Xing, L Luan, H Xu, RB Sharma, A Popovic, TM Pawlik, ...
Clinical Cancer Research 23 (23), 7333-7339, 2017
1352017
Axon guidance molecules promote perineural invasion and metastasis of orthotopic pancreatic tumors in mice
NR Jurcak, AA Rucki, S Muth, E Thompson, R Sharma, D Ding, Q Zhu, ...
Gastroenterology 157 (3), 838-850. e6, 2019
1162019
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/E2F transcription factor 1–dependent apoptotic …
HX Sun, Y Xu, XR Yang, WM Wang, H Bai, RY Shi, SK Nayar, ...
Hepatology 57 (3), 1088-1097, 2013
1002013
The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma
J Ai, Q Tang, Y Wu, Y Xu, T Feng, R Zhou, Y Chen, X Gao, Q Zhu, X Yue, ...
Journal of the National Cancer Institute 103 (22), 1696-1712, 2011
982011
Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma
Y Xu, V Chenna, C Hu, HX Sun, M Khan, H Bai, XR Yang, QF Zhu, YF Sun, ...
Clinical Cancer Research 18 (5), 1291-1302, 2012
792012
Pharmacological activation of myosin II paralogs to correct cell mechanics defects
A Surcel, WP Ng, H West-Foyle, Q Zhu, Y Ren, LB Avery, AK Krenc, ...
Proceedings of the National Academy of Sciences 112 (5), 1428-1433, 2015
712015
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human …
B Hu, D Sun, C Sun, YF Sun, HX Sun, QF Zhu, XR Yang, YB Gao, ...
Biochemical and biophysical research communications 468 (4), 525-532, 2015
682015
Targeting mechanoresponsive proteins in pancreatic cancer: 4-hydroxyacetophenone blocks dissemination and invasion by activating MYH14
A Surcel, ES Schiffhauer, DG Thomas, Q Zhu, K DiNapoli, M Herbig, ...
Biophysical Journal 116 (3), 260a, 2019
662019
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
WJ Ho, Q Zhu, J Durham, A Popovic, S Xavier, J Leatherman, A Mohan, ...
Nature Cancer 2 (9), 891-903, 2021
642021
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ...
Cancer Cell 40 (11), 1374-1391. e7, 2022
632022
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
M Yarchoan, L Cope, AN Ruggieri, RA Anders, AM Noonan, LW Goff, ...
The Journal of Clinical Investigation 131 (24), 2021
572021
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
M Yarchoan, CY Huang, Q Zhu, AK Ferguson, JN Durham, RA Anders, ...
Cancer medicine 9 (4), 1485-1494, 2020
572020
Histopathological and immunophenotypic features of ipilimumab‐associated colitis compared to ulcerative colitis
BL Adler, MK Pezhouh, A Kim, L Luan, Q Zhu, F Gani, M Yarchoan, ...
Journal of internal medicine 283 (6), 568-577, 2018
512018
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
KN Smith, NJ Llosa, TR Cottrell, N Siegel, H Fan, P Suri, HY Chan, H Guo, ...
Journal for immunotherapy of cancer 7, 1-8, 2019
452019
Yes-associated protein impacts adherens junction assembly through regulating actin cytoskeleton organization
RAA Haibo Bai, Qingfeng Zhu, Alexandra Surcel, Tianzhi Luo, Yixin Ren, Bin ...
American Journal of Physiology - Gastrointestinal and Liver Physiology 311 …, 2016
422016
Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors
C Gong, RA Anders, Q Zhu, JM Taube, B Green, W Cheng, IH Bartelink, ...
Frontiers in oncology 8, 649, 2019
412019
系统目前无法执行此操作,请稍后再试。
文章 1–20